XP Chemistries AB
STO:XPC
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0315
0.248
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
XP Chemistries AB
Revenue
XP Chemistries AB
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
X
|
XP Chemistries AB
STO:XPC
|
Revenue
kr663.7k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hexpol AB
STO:HPOL B
|
Revenue
kr22B
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
H
|
Humble Group AB
STO:HUMBLE
|
Revenue
kr7.1B
|
CAGR 3-Years
505%
|
CAGR 5-Years
366%
|
CAGR 10-Years
N/A
|
|
|
P
|
Polygiene Group AB
STO:POLYG
|
Revenue
kr143.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
O
|
OrganoClick AB
STO:ORGC
|
Revenue
kr133.7m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
21%
|
|
|
I
|
I-Tech AB
STO:ITECH
|
Revenue
kr146.9m
|
CAGR 3-Years
41%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
XP Chemistries AB
Glance View
XP Chemistries AB engages in biotechnology research and experimental development. The company is headquartered in Sundsvall, Vasternorrland. The company went IPO on 2021-10-29. The firm has an international patent portfolio covering sustainable nature-inspired technologies optimal combinations of catalytic processes for the production of bio-based chemicals.
See Also
What is XP Chemistries AB's Revenue?
Revenue
663.7k
SEK
Based on the financial report for Dec 31, 2023, XP Chemistries AB's Revenue amounts to 663.7k SEK.
What is XP Chemistries AB's Revenue growth rate?
Revenue CAGR 1Y
-37%
Over the last year, the Revenue growth was -37%.
You don't have any saved screeners yet
